Phreesia, Inc. Common Stock (N:PHR)

Mar 19, 2024 06:48 am ET
Phreesia Announces Jack Callahan as New Chief Technology Officer
Phreesia, a leader in patient intake, outreach and activation, has named Jack Callahan as the company’s new Chief Technology Officer. Callahan previously served as Phreesia’s Vice President of Engineering and has been with the company for 14 years. He succeeds Dan Nathan, who has been with the company for 17 years and played an integral role in establishing Phreesia’s technical capabilities. Nathan will remain with the company as Senior Engineering Advisor.
Mar 14, 2024 04:03 pm ET
Phreesia Announces Fourth Quarter Fiscal 2024 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2024.
Feb 27, 2024 04:05 pm ET
Phreesia’s Hilary Hatch Again Named to the 2024-2025 NQF Leadership Consortium
Phreesia is proud to announce that its Chief Clinical Officer Hilary Hatch, PhD, has been selected to participate in the National Quality Forum (NQF)’s 2024-2025 Leadership Consortium. Dr. Hatch is one of onl
Feb 20, 2024 06:48 am ET
New Data Shows That Engaging Patients with Relevant Cancer-Prevention Information During Check-In Increases Screening Rates
Phreesia, a leader in patient intake, outreach and activation, is proud to release data from an analysis of its cancer prevention campaigns illustrating the significant impact its platform can have on increasing rates of cancer screenings. By engaging patients at critical moments in their healthcare journey,
Feb 05, 2024 04:05 pm ET
Phreesia Sets Release Date for Fiscal Fourth Quarter 2024 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal fourth quarter 2024 financial results after the close of market trading on Thursday, March 14, 2024. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at
Jan 23, 2024 06:40 am ET
Phreesia Joins Call to Action to Improve Adult Vaccination Rates
Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that it has joined the National Adult and Influenza Immunization Summit’s Call to Action for Adult Immunizations campaign to improve adult vaccination rates.
Jan 16, 2024 04:05 pm ET
Phreesia’s Audrey Gato Named as a Top Woman Leader in SaaS
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Audrey Gato, Vice President of Client Solutions, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2023.
Jan 11, 2024 06:44 am ET
Phreesia’s Post-Script Engagement named one of PM360’s 2023 Most Innovative Technologies
Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named the Post-Script Engagement, Phreesia’s new medication adherence solution, to its list of 2023 Most Innovative Marketing Technologies or Services.
Dec 05, 2023 04:03 pm ET
Phreesia Announces Third Quarter Fiscal 2024 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal third quarter ended October 31, 2023.
Dec 01, 2023 06:00 am ET
CMS Includes the Patient Activation Measure in its Merit-Based Incentive Payment System Starting in 2024
Phreesia is very pleased to announce that the Centers for Medicare and Medicaid Services (CMS) has included the Patient Activation Measure Performance Measure (PAM-PM) in its Merit-Based Incentive Payment System (MIPS), as well as in 15 specialty-specific measure sets and five MIPS Value Pathways (MVPs), subsets of measures for specific conditions.
Nov 08, 2023 06:00 am ET
Phreesia Achieves HITRUST Risk-Based, 2-Year Certification Demonstrating the Highest Level of Information Protection Assurance
Phreesia today announced its patient intake platform and data centers have earned certified status by HITRUST for information security.
Nov 01, 2023 06:03 am ET
Phreesia Sets Release Date for Fiscal Third Quarter 2024 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal third quarter 2024 financial results after the close of market trading on Tuesday, December 5, 2023. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at
Sep 06, 2023 04:03 pm ET
Phreesia Announces Second Quarter Fiscal 2024 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2023.
Aug 16, 2023 12:58 pm ET
Phreesia Named to The Software Report’s “Top 100 Software Companies” for the Second Consecutive Year
Phreesia, a leader in patient intake, outreach and activation, is pleased to announce it has been selected by The Software Report as one of the “Top 100 Software Companies of 2023.” The annual program evaluates companies based on a range of factors, including product function
Aug 15, 2023 05:11 pm ET
Phreesia Awards Inducement Grants as Part of its Acquisition of Access eForms
On July 13, 2023, Phreesia, Inc.’s (“Phreesia”) Board of Directors approved the grant of restricted stock unit awards pursuant to Phreesia’s 2023 Inducement Award Plan (the “Plan”). On August 15, 2023, Phreesia made grants pursuant to the Plan in an aggregate amount of 12,285 shares of its common stock to 24 new non-executive employees to induce them to join Phreesia. The awards vest annually in equal installments over a four-year period following their grant, subject to continued employment. Each award was granted as a material inducement to employment in accordance with the NYSE Listed Compa
Aug 14, 2023 04:03 pm ET
Phreesia Acquires Access, Expanding its Offerings for Acute-Care Hospitals and Continuing to Drive Efficiency and a Better Patient Experience
Phreesia, a leader in patient intake, outreach and activation, is pleased to announce it has acquired Access eForms, an innovative electronic forms management and automation provider that helps hospitals across the country streamline workflows, improve compliance and deliver a better patient experience.
Aug 01, 2023 06:03 am ET
Phreesia Sets Release Date for Fiscal Second Quarter 2024 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal second quarter 2024 financial results after the close of market trading on Wednesday, September 6, 2023. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at
Jul 14, 2023 04:48 pm ET
Phreesia Acquires MediFind, Reinforcing its Commitment to Patient-Centered Care and Expanding its Offerings to Consumers
Phreesia, a leader in patient intake, outreach and activation, is pleased to announce it has acquired Comsort, Inc. d/b/a MediFind (“MediFind”), a health technology company that uses advanced analytics to help patients—especially those with serious, chronic and rare diseases—find better care faster.
Jul 13, 2023 04:03 pm ET
Phreesia Names Lisa Egbuonu-Davis to its Board of Directors
Phreesia is pleased to announce it has named Lisa Egbuonu-Davis, M.D., MPH, MBA, as the newest member of its board of directors, effective July 13, 2023. Dr. Egbuonu-Davis is the former Vice President, Medical Innovations for DH Diagnostics, LLC, an affiliate of Danaher Corporation, where she provided medical advice to influence research, partnership and investment strategy across Danaher’s diagnostic platform businesses.
May 31, 2023 04:03 pm ET
Phreesia Announces First Quarter Fiscal 2024 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2023.
May 17, 2023 04:03 pm ET
Phreesia Recognized as One of Modern Healthcare’s “Best Places to Work in Healthcare” for a Seventh Year
Phreesia, a leader in patient intake, outreach and activation, has been selected by Modern Healthcare as one of the 2023 Best Places to Work in Healthcare. This is the seventh time Phreesia has been named to the list.
May 16, 2023 04:05 pm ET
Phreesia’s Hilary Hatch Named a “Disrupter” in PM360’s ELITE 100
Phreesia is pleased to announce that Hilary Hatch, PhD, Phreesia’s Chief Clinical Officer, has been named as one of the 2023 PM360 ELITE 100 by healthcare-marketing trade publication, PM360.
Apr 25, 2023 04:04 pm ET
Phreesia Sets Release Date for Fiscal First Quarter 2024 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2024 financial results after the close of market trading on Wednesday, May 31, 2023. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at
Mar 29, 2023 04:03 pm ET
Unlimited Systems Partners with Phreesia, Improving Efficiency and Offering an Integrated Patient-Driven Intake Experience for Oncology Groups
Unlimited Systems, a leading revenue cycle application provider for specialty healthcare, and Phreesia, a leader in patient intake, outreach and activation, are partnering to offer a new integration that allows independent oncology practices and health systems to enhance the patient experience and reduce staff burden.
Mar 22, 2023 04:03 pm ET
Phreesia Announces Chief Financial Officer Transition
Phreesia, Inc. (NYSE: PHR), a leader in patient intake, outreach and activation, today announced the appointment of Balaji Gandhi as Phreesia’s Chief Financial Officer. Gandhi will succeed Randy Rasmussen, effective March 24, 2023. Rasmussen will serve as a Strategic Advisor to the Company for a period of time, to facilitate a smooth transition of his responsibilities.
Mar 22, 2023 04:03 pm ET
Phreesia Announces Fourth Quarter Fiscal 2023 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2023.
Mar 20, 2023 04:04 pm ET
Phreesia Named as One of the Achievers 50 Most Engaged Workplaces® of 2023
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that it has been named as one of the 2023 Achievers 50 Most Engaged Workplaces®. This annual award recognizes top employers that display leadership and innovation in engaging their workplaces, with past winne
Mar 17, 2023 06:50 am ET
Phreesia’s Alexandra Beneville Named One of MM+M’s ‘Women to Watch’ for 2023
Phreesia is pleased to announce that the healthcare marketing industry trade publication MM+M has named Alexandra Beneville, Vice President, Life Sciences Content Strategy, to its Women to Watch class of 2023.
Mar 15, 2023 04:05 pm ET
Phreesia’s Dan Nathan Named as a Top Software CTO of 2023
Phreesia, a leader in patient intake, outreach and activation, is proud to announce that Dan Nathan, the company’s Chief Technology Officer, has been named to The Software Report’s list of the Top 25 Software CTOs of 2023.
Feb 02, 2023 06:38 am ET
Phreesia Sets Release Date for Fiscal Fourth Quarter 2023 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal fourth quarter 2023 financial results after the close of market trading on Wednesday, March 22, 2023. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at
Jan 31, 2023 04:03 pm ET
Phreesia Included in 2023 Bloomberg Gender-Equality Index for the Third Consecutive Year
Phreesia, a leader in patient intake, outreach and activation, is joining 483 other companies as a member of the 2023 Bloomberg Gender-Equality Index (GEI). This reference index measures gender equality across five pillars: leadership and talent pipeline, equal pay and gender pay parity, inclusive culture, anti-sexual harassment policies and external brand.
Jan 26, 2023 06:45 am ET
Phreesia and the Ad Council Partnership Drives Strong Engagement Across 3 Public Health Campaigns
Phreesia, a leader in patient intake, outreach and activation, along with the Ad Council, a nonprofit organization at the forefront of driving change through social impact marketing, have collaborated to bring three public health campaigns directly to patients and caregivers. Initial results show the campaigns are helping to raise awareness about critical health issues and encouraging important conversations between patients, caregivers and healthcare providers.
Jan 20, 2023 05:18 pm ET
Phreesia Life Sciences Named One of MM+M’s “Best Places to Work 2022”
Phreesia, a leader in patient intake, outreach and activation, is pleased to announce that for the second year in a row, the healthcare marketing industry trade publication Medical Marketing and Media (MM+M) has named Phreesia Life Sciences to its list of Best Places to Work 2022.
Dec 08, 2022 04:03 pm ET
Phreesia Announces Third Quarter Fiscal 2023 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the third quarter ended October 31, 2022.
Nov 16, 2022 04:41 pm ET
Phreesia’s Sara DiNardo Selected as a Top Woman Leader in SaaS
Phreesia is proud to announce that Sara DiNardo, the company’s Vice President of Client Solutions, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2022.
Oct 28, 2022 04:10 pm ET
Phreesia Sets Release Date for Fiscal Third Quarter 2023 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal third quarter 2023 financial results after the close of market trading on Thursday, December 8, 2022. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at
Sep 22, 2022 04:27 pm ET
Phreesia Names Alexandra Beneville Vice President of Life Sciences Content Strategy
Phreesia, a leader in patient intake, outreach and activation, has named Alexandra Beneville as Vice President of Life Sciences Content Strategy. Beneville officially joined Phreesia on Aug. 1, 2022, from Phosphorus, a direct-to-consumer genomic testing company, where she had served as Vice President of Marketing since December 2021.
Sep 16, 2022 04:46 pm ET
Phreesia’s Zeeshan Butt Named to NQF’s MAP Clinician Workgroup
Phreesia is proud to announce that Zeeshan Butt, PhD, a Director of Clinical Content, has been selected to serve a three-year term as a member of the National Quality Forum (NQF)’s Measure Applications Partnership (MAP) 2022-2023 Clinician Workgroup.
Sep 07, 2022 04:03 pm ET
Phreesia Announces Fiscal Second Quarter 2023 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal second quarter ended July 31, 2022.
Jul 29, 2022 06:50 am ET
Phreesia Sets Release Date for Fiscal Second Quarter 2023 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal second quarter 2023 financial results after the close of market trading on Wednesday, September 7, 2022. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at
Jul 20, 2022 06:50 am ET
Phreesia Named to The Software Report’s “Top 100 Software Companies of 2022”
Phreesia is pleased to announce that it has been named to The Software Report’s list of “The Top 100 Software Companies of 2022.” The annual award recognizes the best companies leading the software industry forward, considering criteria including product quality, organiza
Jun 22, 2022 06:50 am ET
New Phreesia Research Reveals Patients’ Changing Preferences for their Digital Healthcare Experience
Patients’ expectations of healthcare technology are changing to reflect the digital conveniences they are used to in other aspects of their lives, according to research in a newly published white paper from Phreesia. Based on the results of a survey of 4,136 patients, the paper sheds light on the consu
Jun 07, 2022 06:45 am ET
Compulink and Phreesia Partner to Help Practices Increase Efficiency and Profitability with an Integrated Intake Solution
Compulink Healthcare Solutions, a leader in specialty-specific all-in-one EHR solutions; and Phreesia, a leader in patient intake, outreach and activation, are pleased to announce that they have partnered to offer a robust, bidirectional integration between their systems. This integration will help practices save time, increase patient collections, improve patient satisfaction, and keep their schedules full.
Jun 02, 2022 04:03 pm ET
Phreesia Announces Fiscal First Quarter 2023 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal first quarter ended April 30, 2022.
May 26, 2022 04:05 pm ET
KLAS and Phreesia Partner to Deliver Patient Insights on Healthcare Technology
KLAS, a healthcare research and insights firm, and Phreesia, a leader in patient intake, outreach and activation, are pleased to announce the release of a report that aims to shed light on patients’ preferen
May 24, 2022 06:45 am ET
Phreesia Named One of Becker’s Healthcare’s “150 Top Places to Work in Healthcare”
Phreesia is excited to announce it has been selected by Becker’s Healthcare as one of this year’s 150 Top Places to Work in Healthcare. The list highlights hospitals, health systems and healthcare companies that promote diversity within the workforce, emplo
May 19, 2022 06:45 am ET
Phreesia Selected as One of Modern Healthcare’s “Best Places to Work in Healthcare” for a Sixth Year
Phreesia is excited to announce it has been selected by Modern Healthcare as one of the 2022 Best Places to Work in Healthcare. This is the sixth time Phreesia has been named to the list.
May 17, 2022 04:00 pm ET
Phreesia’s Danielle Lynch Named a ‘Sales MVP’ in PM360’s ELITE 100
Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named Danielle Lynch, Vice President, Client Experience, as one of the 2022 PM360 ELITE 100.
Apr 29, 2022 06:30 am ET
Phreesia Sets Release Date for Fiscal First Quarter 2023 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) today announced that it will release its fiscal first quarter 2023 financial results after the close of market trading on Thursday, June 2, 2022. Phreesia will issue a press release announcing its quarterly results and the company’s quarterly stakeholder letter, both of which will be posted on its investor website at
Mar 31, 2022 04:15 pm ET
Phreesia’s Danielle Lynch Named One of MM+M’s ‘Women to Watch’ for 2022
Phreesia is pleased to announce that the healthcare marketing industry trade MM+M has named Danielle Lynch, Vice President, Client Experience, to its Women to Watch class of 2022.
Mar 30, 2022 04:02 pm ET
Phreesia Announces Fiscal Year Ended January 31, 2022 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia” or the "Company") announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2022.
Feb 28, 2022 04:33 pm ET
Phreesia Sets Release Date for Fiscal Fourth Quarter 2022 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will hold a conference call on Wednesday, March 30, 2022, at 5:00 p.m. Eastern Time to discuss the Company's fiscal fourth quarter 2022 financial results. A press release announcing the fiscal fourth quarter financial results will be issued prior to the conference call, after the close of market trading, on Wednesday, March 30, 2022.
Feb 08, 2022 04:05 pm ET
Phreesia Named 2022 Best in KLAS for Patient Intake Management for a Fourth Year
Phreesia (NYSE: PHR) is pleased to announce it has been named 2022 Best in KLAS for Patient Intake Management by the research and insights firm KLAS. In its annual report, “2022 Best in KLAS: Software and Services,” KLAS recognized the healthcare IT and services companies who excel in helping healthcare professionals improve patient care.
Jan 28, 2022 06:55 am ET
Phreesia’s Amy VanDuyn Named a Top 10 HR Professional at the OnCon Icon Awards
Phreesia is proud to announce that Amy VanDuyn, the company’s SVP of Human Resources, has been named a Top 10 HR Professional at the 2022 OnCon Icon Awards. The awards recognize the top human resources professionals and vendors worldwide.
Jan 26, 2022 08:00 am ET
Phreesia Included in the 2022 Bloomberg Gender-Equality Index for the Second Year
Phreesia is pleased to announce that it is one of 418 companies across 45 countries and regions to join the 2022 Bloomberg Gender-Equality Index (GEI). This reference index measures gender equality across five pillars: female leadership and talent pipeline, equal pay and gender pay parity, inclusive culture, anti-sexual harassment policies and pro-women brand.
Jan 20, 2022 08:30 am ET
Phreesia Joins Greenfield, MEDITECH’s Application Developer Environment
Phreesia is pleased to announce that it is now a part of MEDITECH Greenfield, a testing ground for apps that can integrate with MEDITECH Expanse. This collaboration with MEDITECH will allow Phreesia to better enable patients to take a more active role in their care.
Jan 18, 2022 04:15 pm ET
Phreesia Life Sciences’ PatientInsights Named one of PM360’s 2021 Most Innovative Services
Phreesia is pleased to announce that the healthcare marketing industry trade publication PM360 has named PatientInsights, Phreesia Life Sciences’ market research platform, to its list of 2021 Most Innovative Services.
Dec 17, 2021 11:52 am ET
Phreesia Life Sciences Named one of MM+M’s “Best Places to Work 2021”
Phreesia is pleased to announce that the healthcare marketing industry trade publication Medical Marketing and Media (MM+M) has named Phreesia Life Sciences to its list of Best Places to Work 2021.
Dec 13, 2021 08:30 am ET
Phreesia Announces Acquisition of Insignia Health, LLC, Redoubling Its Commitment to Improve Patients’ Experience and Outcomes
Phreesia is excited to announce it has acquired Insignia Health, LLC, a founder-led and mission-oriented company dedicated to improving health outcomes through patient activation. The acquisition is a natural extension of Phreesia’s commitment to enabling patients to become more active participants in their care.
Dec 08, 2021 04:05 pm ET
Phreesia Announces Fiscal Third Quarter 2022 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) announced financial results today for the fiscal third quarter ended October 31, 2021.
Nov 01, 2021 08:30 am ET
Phreesia Sets Release Date for Fiscal Third Quarter 2022 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will hold a conference call on Thursday, December 9, 2021, at 8:45 a.m. Eastern Time to discuss the Company's fiscal third quarter 2022 financial results. A press release announcing the fiscal third quarter financial results will be issued after the close of market trading on Wednesday, December 8, 2021.
Oct 28, 2021 08:30 am ET
Phreesia’s Allison Hoffman Named a Top Woman Leader in SaaS
Phreesia is proud to announce that Allison Hoffman, the company’s General Counsel, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2021.
Oct 26, 2021 08:30 am ET
Phreesia Names Ramin Sayar to its Board of Directors
Phreesia is pleased to announce it has named Ramin Sayar as the newest member of its board of directors, effective October 1. Mr. Sayar is President and CEO of Sumo Logic (Nasdaq: SUMO), the pioneer in continuous intelligence, a new category of software which enables organizations to address the data challenges and opportunities presented by digital transformation, modern applications and cloud computing.
Oct 05, 2021 08:30 am ET
MercyOne and Phreesia Partner to Address Unmet Social Needs of Patients
MercyOne and Phreesia are celebrating an innovative initiative to evaluate and deliver resources to meet the needs of individuals in the communities we serve. Through its partnership with health care technology company Phreesia, MercyOne has streamlined the process for providing patients resources they need while improving the consumer experience.
Sep 08, 2021 08:15 am ET
Phreesia Again Achieves HITRUST CSF® Certification for Enhanced Security and Compliance
Phreesia is pleased to announce that its patient intake platform has earned renewed HITRUST CSF Certification for information security. The designation validates Phreesia’s commitment to meeting key regulations and protecting sensitive information.
Sep 01, 2021 04:10 pm ET
Phreesia Announces Fiscal Second Quarter 2022 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) announced financial results today for the fiscal second quarter ended July 31, 2021.
Aug 24, 2021 04:30 pm ET
Phreesia’s Chaim Indig Named One of The Software Report’s Top 50 SaaS CEOs of 2021
Phreesia is pleased to announce that Chaim Indig, Chief Executive Officer of Phreesia, has been named to The Software Report’s list of the Top 50 SaaS CEOs of 2021.
Aug 02, 2021 04:30 pm ET
Phreesia Sets Release Date for Fiscal Second Quarter 2022 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will hold a conference call on Thursday, September 2, 2021, at 8:30 a.m. Eastern Time to discuss the Company's fiscal second quarter 2022 financial results. A press release announcing the fiscal second quarter financial results will be issued after the close of market trading on Wednesday, September 1, 2021.
Jul 22, 2021 08:30 am ET
Phreesia Partners with Safe Environment for Every Kid (SEEK) to Automate Delivery of its Screening Tool
Phreesia is pleased to partner with the developers of the Safe Environment for Every Kid (SEEK) model to deliver their screening tool for adverse childhood experiences (ACEs) and negative social determinants of health (SDOH) to pediatric primary care providers across Phreesia’s network. This automated questionnaire will enhance pediatricians’ ability to provide high-quality, comprehensive care to their patients, and to promote the well-being of the children and families they serve.
Jul 09, 2021 08:16 am ET
Phreesia’s New Appointment Accelerator Transforms Medical Scheduling, Reducing Wait Times and Improving Patient Access
Phreesia is pleased to announce that it has launched Appointment Accelerator, a cutting-edge solution that allows healthcare providers to automatically fill cancelled appointments, reduce no-shows and improve patient access—all without any staff involvement.
Jun 03, 2021 04:10 pm ET
Phreesia Announces Fiscal First Quarter 2022 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) announced financial results today for the fiscal first quarter ended April 30, 2021.
May 17, 2021 08:44 am ET
Phreesia Selected as One of Modern Healthcare’s “Best Places to Work” for a Fifth Year
Phreesia, the nation’s leader in patient intake, is excited to announce it has been selected by Modern Healthcare as one of the 2021 Best Places to Work in Healthcare. This is the fifth time Phreesia has been named to the magazine’s list.
May 14, 2021 10:45 am ET
Phreesia’s David Linetsky Named a ‘Transformational Leader’ in PM360’s Elite 100
Phreesia is pleased to announce that the healthcare marketing industry trade PM360 has named David Linetsky, Senior Vice President of Life Sciences, as one of the 2021 PM360 ELITE 100.
May 06, 2021 08:15 am ET
Phreesia Sets Release Date for Fiscal First Quarter 2022 Financial Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will hold a conference call on Friday, June 4, 2021, at 8:30 a.m. Eastern Time to discuss the Company's fiscal first quarter 2022 financial results. A press release announcing the fiscal first quarter financial results will be issued after the close of market trading on Thursday, June 3, 2021.
Apr 21, 2021 08:00 am ET
Phreesia and Ad Council Partnership Yields High Engagement in Alzheimer’s Awareness Campaign
Phreesia, the nation’s leader in patient intake, and the Ad Council, a nonprofit organization that produces, distributes and drives impact through public service communications, have partnered to bring the Ad Council’s ongoing awareness campaign with the Alzheimer’s Association directly to patients and caregivers. Initial results from the campaign extension show that over half the people who engaged with the campaign as they checked in for a healthcare visit on Phreesia’s digital platform were likely to talk to a doctor about Alzheimer’s disease.
Apr 12, 2021 04:10 pm ET
Phreesia Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Phreesia, Inc. (the “Company”) (NYSE:PHR), a leading patient intake management platform, announced today the closing of the underwritten public offering of 5,175,000 shares of its common stock (the “Offering”) all of which were sold by the Company, which includes the full exercise of the underwriters’ option to purchase 675,000 additional shares of common stock. The shares were sold at a public offering price of $50.00 per share and were purchased by the underwriters from the Company at the public offering price, less the underwriting discount.
Apr 07, 2021 10:23 pm ET
Phreesia Announces Pricing of Public Offering of Common Stock
Phreesia, Inc. (“Phreesia”) (NYSE:PHR), a leading patient intake management platform, announced today the pricing of its previously announced underwritten public offering of 4,500,000 shares of its common stock (the “Offering”) at a price to the public of $50.00 per share, all of which will be sold by the Company. In addition, the Company has granted the underwriters an option for 30 days to purchase up to 675,000 additional shares of common stock at the public offering price, less underwriting discounts.
Apr 06, 2021 04:10 pm ET
Phreesia Announces Proposed Public Offering of Common Stock
Phreesia, Inc. (“Phreesia”) (NYSE: PHR), a leading patient intake management platform, announced today that it has commenced an underwritten public offering of 4,500,000 shares of its common stock (the “Offering”), to be offered by the Company. In addition, the Company expects to grant to the underwriters an option for 30 days to purchase up to 675,000 additional shares of common stock at the public offering price, less underwriting discounts. The Offering is subject to market and other conditions, and there can be no assurances as to whether or when the Offering may be completed, or as to the
Mar 30, 2021 04:10 pm ET
Phreesia Announces Fiscal Year End 2021 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) announced financial results today for the fiscal fourth quarter and fiscal year ended January 31, 2021.
Mar 30, 2021 08:30 am ET
Phreesia and New Jersey Urology Partner to Standardize Intake and Improve Patient Experience
Phreesia is pleased to announce it has partnered with New Jersey Urology (NJU), New Jersey’s largest urology services provider, to standardize the patient intake process across NJU’s more than 60 locations, increasing efficiency, improving clinical care and providing an engaging, convenient patient experience.
Mar 09, 2021 09:46 am ET
Phreesia Partners with CONVINCE USA on Vaccine Hesitancy Initiative
Phreesia, the nation’s leading patient intake platform, is pleased to announce it has partnered with the CONVINCE USA initiative at the CUNY Graduate School of Public Health & Health Policy (CUNY SPH) to create a patient survey and data-driven education tool to better understand and address patients’ COVID-19 vaccine hesitancy. To date, more than 300,000 survey responses have been collected across Phreesia’s nationwide network, providing valuable insights that can enable targeted interventions to engage and inform more hesitant groups and shed light on the relationship between access and hesit
Feb 25, 2021 08:16 am ET
Phreesia Sets Release Date for Fiscal Fourth Quarter and Full Year 2021 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will issue a press release that includes the company’s fiscal fourth quarter and full year 2021 financial results after the close of market trading on Tuesday, March 30, 2021. The Company will host a conference call and webcast to review the quarterly results on Wednesday, March 31, 2021, at 8:30 a.m. Eastern Time.
Feb 02, 2021 08:00 am ET
Phreesia Named 2021 Best in KLAS for Patient Intake Management
Phreesia today announced it has been named 2021 Best in KLAS for Patient Intake Management by the research and insights firm KLAS. In its annual report, “2021 Best in KLAS: Software and Services,” KLAS recognized the industry’s top-performing healthcare IT and services companies, based on feedback from healthcare organizations.
Jan 29, 2021 10:07 am ET
Phreesia Named to 2021 Bloomberg Gender-Equality Index, Highlighting Its Commitment to an Inclusive Workplace
Phreesia, the nation’s leading patient intake management platform, is pleased to announce that it is one of 380 companies across 11 sectors included in the 2021 Bloomberg Gender-Equality Index (GEI). The GEI expanded in 2021 to represent 44 countries and regions, including firms headquartered in Indonesia and Bermuda for the first time. Companies range from a variety of industries, including automotive, banking, consumer services, engineering and construction, and retail.
Jan 26, 2021 11:56 am ET
Phreesia Receives Certification from the Point of Care Communication Council, Based on Audit by the Alliance for Audited Media
Phreesia, the nation’s leading patient intake platform, is pleased to announce that as a result of ongoing auditing by the Alliance for Audited Media (AAM), the industry leader in media verification, it has received certification from the
Dec 21, 2020 08:00 am ET
Phreesia Joins Zoom App Marketplace to Create a Better Telehealth Experience
Phreesia, the nation’s leading patient intake platform, is pleased to announce that it is now listed on the Zoom App Marketplace, expanding provider access through its Intake for Telehealth offering. Through the integration of Zoom with Phreesia's platform, we offer an automated solution that streamlines and simplifies patient intake during telehealth visits.
Dec 10, 2020 08:00 am ET
Office Practicum and Phreesia Partner to Offer Seamlessly Integrated Patient Intake to Pediatric Practices
Office Practicum (OP), a leading provider of pediatric-specific EHR, practice management and revenue cycle management solutions, and Phreesia, the nation’s leading patient intake management platform, are pleased to announce that they have partnered to offer robust, bidirectional integration between their systems, helping pediatric groups improve operations and create the healthcare experience that parents and families want.
Dec 08, 2020 04:22 pm ET
Phreesia Announces Planned CFO Transition in 2021: Chief Financial Officer Tom Altier to Retire, Randy Rasmussen Named New CFO
Phreesia, Inc. (NYSE: PHR) today announced that Tom Altier, its Chief Financial Officer, will retire in April 2021. Randy Rasmussen, the company’s Chief Accounting Officer, will succeed Altier as CFO, effective May 1, 2021. Altier, who joined Phreesia in 2012, will continue in his current role through the end of April 2021 and the filing of Phreesia’s Annual Report on Form 10-K, and thereafter will continue to support the company in an advisory role.
Dec 08, 2020 04:11 pm ET
Phreesia Announces Fiscal Third Quarter 2021 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) announced financial results today for the fiscal third quarter ended October 31, 2020.
Nov 13, 2020 10:20 am ET
Phreesia Sets Release Date for Fiscal Third Quarter 2021 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will issue a press release that includes the company’s fiscal third quarter 2021 financial results after the close of market trading on Tuesday, December 8, 2020. Phreesia will host a conference call and webcast on Wednesday, December 9, 2020, at 8:30 a.m. Eastern Time to review the quarterly results.
Nov 10, 2020 12:00 pm ET
Phreesia Recognized for Highest Overall Performance in New KLAS Report on Patient Intake Management Solutions
Phreesia is honored to be recognized by the research and insights firm KLAS as the patient intake management solution with the highest overall score and the highest COVID-19 response rating in a new report entitled, “Patient Intake Management 2020: Helping Clinics Keep Their Doors Open During COVID-19.”
Oct 26, 2020 08:00 am ET
Phreesia’s Kristin Roberts Named a Top Woman Leader in SaaS
Phreesia, the nation’s leading patient intake platform, is pleased to announce that Kristin Roberts, the company’s Vice President of Market Development, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2020.
Oct 23, 2020 04:10 pm ET
Phreesia Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Phreesia, Inc. (“Phreesia” or the “Company”) (NYSE: PHR), a leading patient intake management platform, announced today the closing of the underwritten public offering of 5,750,000 shares of its common stock (the “Offering”), all of which were sold by the Company, which includes the full exercise of the underwriters’ option to purchase 750,000 additional shares of common stock. The shares were sold at a public offering price of $32.00 per share and were purchased by the underwriters from the Company at the public offering price, less the underwriting discount.
Oct 21, 2020 07:30 am ET
Phreesia Announces Pricing of Public Offering of Common Stock
Phreesia, Inc. (“Phreesia”) (NYSE:PHR), a leading patient intake management platform, announced today the pricing of its previously announced underwritten public offering of 5,000,000 shares of its common stock (the “Offering”) at a price to the public of $32.00 per share, all of which will be sold by the Company. In addition, the Company has granted the underwriters an option for 30 days to purchase up to 750,000 additional shares of common stock at the public offering price, less underwriting discounts.
Oct 19, 2020 04:15 pm ET
Phreesia Announces Proposed Public Offering of Common Stock
Phreesia, Inc. (“Phreesia”) (NYSE: PHR), a leading patient intake management platform, announced today that it has commenced an underwritten public offering of 5,000,000 shares of its common stock (the “Offering”), to be offered by the Company. In addition, the Company expects to grant to the underwriters an option for 30 days to purchase up to 750,000 additional shares of common stock at the public offering price, less underwriting discounts. The Offering is subject to market and other conditions, and there can be no assurances as to whether or when the Offering may be completed, or as to the
Oct 01, 2020 08:00 am ET
Phreesia Acquires Co-Developed Patient Care Applications by Merck and Geisinger
Phreesia, the nation’s leading patient intake platform, is pleased to announce that it has acquired two web-based workflow applications co-developed by Geisinger, a large health system based in Danville, Pa., and Merck, known as MSD outside of the USA and Canada. The newly acquired applications are designed to help improve patient communication and care delivery.
Sep 08, 2020 04:09 pm ET
Phreesia Announces Fiscal Second Quarter 2021 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) announced financial results today for the second quarter ended July 31, 2020.
Aug 24, 2020 07:45 am ET
Phreesia Names Allison Hoffman as General Counsel
Phreesia, (NYSE: PHR) the nation’s leading patient intake platform, has named Allison Hoffman as its General Counsel, effective August 24. Hoffman joins Phreesia from Intersection, a digital technology company focused on improving life in cities and public spaces, where she served as Chief Legal & Administrative Officer since 2016.
Aug 14, 2020 09:00 am ET
Phreesia Sets Release Date for Fiscal Second Quarter 2021 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will issue a press release that includes the company’s fiscal second quarter 2021 financial results after the close of market trading on Tuesday, September 8, 2020. Phreesia will host a conference call and webcast on Wednesday September 9, 2020, at 8:30 a.m. Eastern Time to review the quarterly results.
Aug 13, 2020 09:00 am ET
Phreesia Partners with AdventHealth to Provide Zero-Contact Intake Across its Hospital and Ambulatory Care Settings
Phreesia, the nation’s leading patient intake platform, is proud to announce it has partnered with AdventHealth, one of the nation’s largest faith-based healthcare systems, to provide patients with a safe, contactless intake experience across more than 1,000 AdventHealth hospitals, physician practices and urgent care centers.
Jul 28, 2020 09:00 am ET
Phreesia Names Lainie Goldstein CFO of Take-Two Interactive Software, to its Board of Directors
Phreesia, the nation’s leading patient intake management platform, is pleased to announce it has named Lainie Goldstein as the newest member of its board of directors, effective July 20. Ms. Goldstein is the Chief Financial Officer of Take-Two Interactive Software, Inc., a leading global interactive entertainment company, where she oversees finance, investor relations and corporate communications.
Jul 16, 2020 08:00 am ET
Phreesia Selected as One of Modern Healthcare’s “Best Places to Work in Healthcare” for the Fourth Time
Phreesia, the nation’s leading patient intake management platform, is excited to announce it has been selected by Modern Healthcare as one of the 2020 Best Places to Work in Healthcare for the fourth time.
Jun 16, 2020 08:00 am ET
Phreesia and Brookes Publishing Partner to Expand Delivery of the ASQ-3 Screening Tool and Improve Pediatric Care
Brookes Publishing, a leading provider of professional resources and assessments in early childhood, literacy and special education, and Phreesia, the nation’s leading patient intake platform, are pleased to announce a new partnership to deliver the Ages & Stages Questionnaires®, Third Edition (ASQ®-3), to pediatric patients across Phreesia’s network.
Jun 08, 2020 04:09 pm ET
Phreesia Announces Fiscal First Quarter 2021 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) announced financial results today for the first quarter ended April 30, 2020.
May 22, 2020 08:00 am ET
Phreesia Announces Fiscal First Quarter 2021 Results Release Date
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will hold a conference call on Tuesday, June 9, 2020, at 8:30 a.m. Eastern Time to review the Company's fiscal first quarter 2021 financial results. A press release announcing the fiscal first quarter 2021 financial results will be issued after the close of market trading on Monday, June 8, 2020.
Apr 22, 2020 04:09 pm ET
Phreesia Announces Fiscal Year End 2020 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) announced financial results today for the fiscal fourth quarter and year ended January 31, 2020.
Apr 20, 2020 12:58 pm ET
Memorial Health System and Phreesia Partner to Respond to COVID-19
Memorial Health System, a non-profit health system serving southeastern Ohio and northwestern West Virginia, and Phreesia, the nation’s leading patient intake platform, are proud to announce they have partnered to support Memorial Health System’s response to COVID-19 and to give its patients a safer, better-quality experience.
Mar 25, 2020 09:00 am ET
Phreesia Announces Fiscal Fourth Quarter 2020 Results Release Date
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will hold a conference call on Thursday, April 23, 2020, at 8:30 a.m. Eastern Time to review the Company's fiscal fourth quarter and full year 2020 financial results. A press release announcing the fiscal fourth quarter and full year 2020 financial results will be issued after the close of market trading on Tuesday, April 22, 2020.
Feb 27, 2020 10:41 am ET
Phreesia’s Danielle Lynch Named to MM&M 40 Under 40 List
Phreesia, the nation’s leading patient intake platform, is pleased to announce that Danielle Lynch, the company’s Vice President of Client Experience, has been named to MM&M’s inaugural class of 40 Under 40 honorees. The program recognizes young marketers whose leadership, strategic thinking and digital facility have contributed to the medical marketing industry’s continued evolution and growth.
Jan 31, 2020 10:01 am ET
Phreesia Named 2020 Best in KLAS For Patient Intake Management
Phreesia today announced it has been named 2020 Best in KLAS for Patient Intake Management by the research and insights firm KLAS. In its annual report, “
Dec 17, 2019 11:15 am ET
Phreesia Announces Closing of Secondary Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Phreesia, Inc. (“Phreesia”) (NYSE: PHR), a leading patient intake management platform, announced today the closing of the underwritten secondary public offering of a total of 7,762,500 shares of its common stock (the “Shares”) by certain of Phreesia’s existing stockholders (the “Selling Stockholders”), which includes the full exercise of the underwriters’ option to purchase 1,012,500 additional Shares from the Selling Stockholders. The Shares were sold at a public offering price of $26.00 per share and were purchased by the underwriters from the Selling Stockholders at the public offering pric
Dec 12, 2019 09:26 pm ET
Phreesia Announces Pricing of Secondary Offering
Phreesia, Inc. (“Phreesia”) (NYSE:PHR), a leading patient intake management platform, announced today the pricing of the previously announced underwritten secondary offering of a total of 6,750,000 shares of its common stock at a price to the public of $26.00 per share, all of which will be sold by certain of Phreesia’s existing stockholders (the “Selling Stockholders”). In addition, the Selling Stockholders have granted the underwriters an option for 30 days to purchase up to 1,012,500 additional shares of common stock to cover overallotments, if any, at the public offering price, less the un
Dec 10, 2019 04:49 pm ET
Phreesia Announces Secondary Offering
Phreesia, Inc. (“Phreesia”) (NYSE: PHR), a leading patient intake management platform, announced today the launch of an underwritten secondary public offering of a total of 6,000,000 shares of its common stock (the “Secondary Offering”), to be offered by certain of Phreesia’s existing stockholders (the “Selling Stockholders”). In addition, the Selling Stockholders expect to grant to the underwriters an option for 30 days to purchase up to 900,000 additional shares of common stock to cover overallotments, if any, at the public offering price, less the underwriting discount. Phreesia will not re
Dec 09, 2019 04:10 pm ET
Phreesia Announces Fiscal Third Quarter 2020 Results
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) announced financial results today for the fiscal third quarter and nine months ended October 31, 2019.
Nov 21, 2019 10:15 am ET
Phreesia Announces Fiscal Third Quarter 2020 Earnings Conference Call
Phreesia, Inc. (NYSE: PHR) (“Phreesia”) will hold a conference call on Tuesday, December 10, 2019, at 8:30 a.m. Eastern Time to review the Company's fiscal third quarter 2020 financial results. A press release announcing the fiscal third quarter financial results will be issued after the close of market trading on Monday, December 9, 2019.
Nov 07, 2019 08:00 am ET
Phreesia and Lafayette General Health Partner to Deliver a Better Patient Experience
Lafayette General Health, a non-profit regional health system serving south central Louisiana, and Phreesia, the nation’s leading patient intake platform, are excited to announce they have partnered to offer Lafayette General Health’s patients a more modern, convenient and engaging experience.
Nov 04, 2019 08:00 am ET
Phreesia Names Randy Rasmussen as Chief Accounting Officer
Phreesia, Inc. (NYSE: PHR) the nation’s leading patient intake platform, today announced the appointment of Randy Rasmussen as Chief Accounting Officer, reporting to Tom Altier, Phreesia’s Chief Financial Officer, effective November 1, 2019.
Oct 30, 2019 08:00 am ET
Phreesia’s Kharen Hauck Selected as a Top Woman Leader in SaaS
Phreesia, the nation’s leading patient intake platform, is excited to announce that Kharen Hauck, the company’s Vice President of Demand Generation, has been named to The Software Report’s list of the Top 50 Women Leaders in SaaS of 2019.
Sep 10, 2019 08:00 am ET
Phreesia Partners With the State of North Carolina to Address Whole Person Health Among Its Residents
Phreesia, the leading patient intake platform, is pleased to announce it has partnered with the North Carolina Department of Health and Human Services (NC DHHS) on its Healthy Opportunities Initiative to help address the full set of factors that drive health among people in the state.
Sep 09, 2019 05:45 pm ET
Phreesia Announces Second Quarter of Fiscal 2020 Results
Phreesia, Inc. (NYSE:PHR) (“Phreesia”) announced financial results today for the fiscal second quarter and six months ended July 31, 2019.
Aug 19, 2019 08:56 am ET
Phreesia Announces Fiscal Second Quarter 2020 Earnings Conference Call
NEW YORK, Aug. 19, 2019 /PRNewswire/ -- Phreesia, Inc. (NYSE: PHR) ("Phreesia") will hold a conference call on Tuesday, September 10, 2019, at 8:30 a.m. Eastern Time to review the Company's fiscal second quarter 2020 financial results. A press release announcing the fiscal second quarter financial results will be issued after the close of market trading on Monday, September 9, 2019.
Jul 22, 2019 04:05 pm ET
Phreesia, Inc. Announces Closing of Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
NEW YORK, July 22, 2019 /PRNewswire/ -- Phreesia, Inc. (NYSE: PHR) ("Phreesia"), a leading patient intake management platform, today announced the closing of its initial public offering of 10,681,423 shares of common stock (the "Shares"), consisting of 7,812,500 Shares issued and sold by Phreesia and 2,868,923 shares sold by certain of Phreesia's existing stockholders (the "Selling Stockholders"), which includes the full exercise of the underwriters' option to purchase 1,393,229 additional Shares from the Selling Stockholders, at a public offering price of $18.00 per share. The total gross p
Jul 17, 2019 11:06 pm ET
Phreesia Announces Pricing of Initial Public Offering
NEW YORK, July 17, 2019 /PRNewswire/ -- Phreesia, Inc. ("Phreesia"), a leading patient intake management platform, today announced the pricing of its initial public offering of 9,288,194 shares of common stock at a public offering price of $18.00 per share, before underwriting discounts, consisting of 7,812,500 shares to be issued and sold by Phreesia (the "Primary Shares") and 1,475,694 shares to be sold by certain of Phreesia's existing stockholders (the "Secondary Shares" and, together with the Primary Shares, the "Shares"). The Shares are scheduled to begin trading on the New York Stock
Jul 08, 2019 10:45 am ET
Phreesia Launches Initial Public Offering of Common Stock
NEW YORK, July 8, 2019 /PRNewswire/ -- Phreesia, Inc. ("Phreesia"), a leading patient intake management platform, today announced that it has commenced an initial public offering of its common stock. Phreesia is offering 7,812,500 shares of its common stock at an initial public offering price between $15.00 and $17.00 per share. Certain selling stockholders expect to grant the underwriters a 30-day option to purchase up to an additional 1,171,875 additional shares of common stock. Phreesia intends to list its common stock on the New York Stock Exchange under the ticker symbol "PHR."

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.